M. Karamouzis – Current treatment options for advanced, inoperable, metastatic GIST
J. Duran Moreno – Mechanisms of Resistance of recurrent and metastatic GIST
V. Ramfidis – Lung sarcomas: a study of the Hellenic Group
A. Kyriazoglou – A case series of BCOR sarcomas from the Hellenic Group
E. Skarpidi – NTRK rearranged mesenchymal tumors: pathologic approach
C. Stathopoulos – The dark matter of the genomes: the non coding RNAs in sarcomas
C. Valverde – NTRK in sarcomas. Diagnostic strategy
E. Skarpidi – Changes in WHO classification of STS
R. Jones – Advanced soft tissue sarcomas: Beyond olaratumab
G. Agrogiannis – Extra – uterine leiomyosarcomas, pathology risk
S. Kokkali – Current treatment options in LMS and future perspectives
P. Megas – Osteosarcoma surgical approach
V. Kontogeorgakos – Pelvic sarcomas
J. Y. Blay – WHO classification changes and clinical utility
D.J. Papachristou – Mesenchymal stem cells: key drivers to sarcoma development, diagnosis and …